KOD Quick Ratio | KODIAK SCIENCES INC.

Kodiak Sciences Inc. Quick Ratio

The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

Kodiak Sciences Inc. quick ratio for the quarter ending 2026-06-30 was 2.39, a 28.97% decline year-over-year.
Kodiak Sciences Inc. quick ratio for the quarter ending 2026-03-31 was 3.42, a 23.95% decline year-over-year.
Kodiak Sciences Inc. quick ratio for the quarter ending 2025-12-31 was 4.61, a 29.87% decline year-over-year.
Kodiak Sciences Inc. quick ratio for the quarter ending 2025-09-30 was 1.7, a 79.35% decline year-over-year.
Kodiak Sciences Inc. quick ratio for fiscal 2025 was 4.61, a 29.87% decline from fiscal 2024.
Kodiak Sciences Inc. quick ratio for fiscal 2024 was 6.57, a 3.94% decline from fiscal 2023.
Kodiak Sciences Inc. quick ratio for fiscal 2023 was 6.84, a 25.01% decline from fiscal 2022.
Kodiak Sciences Inc. quick ratio for fiscal 2022 was 9.12, a 19.33% decline from fiscal 2021.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2026-06-30	2.39	$125.9M	$52.77M
2026-03-31	3.42	$169.53M	$49.57M
2025-12-31	4.61	$209.86M	$45.53M
2025-09-30	1.7	$72.04M	$42.43M
2025-06-30	3.36	$104.17M	$31.01M
2025-03-31	4.5	$138.85M	$30.88M
2024-12-31	6.57	$168.07M	$25.57M
2024-09-30	8.22	$197.86M	$24.06M
2024-06-30	10.34	$219.23M	$21.2M
2024-03-31	9.89	$245.92M	$24.86M
2023-12-31	6.84	$285.51M	$41.73M
2023-09-30	4.88	$345.67M	$70.77M
2023-06-30	5.1	$378.67M	$74.24M
2023-03-31	6.11	$421.19M	$68.94M
2022-12-31	9.12	$478.93M	$52.5M
2022-09-30	8.19	$537.4M	$65.6M
2022-06-30	8.56	$597.88M	$69.83M
2022-03-31	8.8	$671.73M	$76.33M
2021-12-31	11.31	$731.51M	$64.68M
2021-09-30	14.69	$799.25M	$54.4M
2021-06-30	21.47	$880.87M	$41.02M
2021-03-31	26.5	$928.99M	$35.06M
2020-12-31	30.84	$968.97M	$31.42M
2020-09-30	16.91	$380.45M	$22.51M
2020-06-30	22.22	$417.13M	$18.77M
2020-03-31	30.49	$421.86M	$13.83M
2019-12-31	28.73	$336.48M	$11.71M
2019-09-30	8.3	$60.6M	$7.3M
2019-06-30	10.96	$68.1M	$6.21M
2019-03-31	16.99	$81.08M	$4.77M
2018-12-31	18.29	$88.25M	$4.83M
2018-09-30	2.15	$11.59M	$5.38M
2017-12-31	0.15	$1.4M	$9.16M

Annual Quick Ratio

Date	Quick Ratio	Quick assets	Current liabilities
2025-12-31	4.61	$209.86M	$45.53M
2024-12-31	6.57	$168.07M	$25.57M
2023-12-31	6.84	$285.51M	$41.73M
2022-12-31	9.12	$478.93M	$52.5M
2021-12-31	11.31	$731.51M	$64.68M
2020-12-31	30.84	$968.97M	$31.42M
2019-12-31	28.73	$336.48M	$11.71M
2018-12-31	18.29	$88.25M	$4.83M
2017-12-31	0.15	$1.4M	$9.16M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
Vericel Corp (VCEL)	United States	$2.011B	93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
Greenland Mines Ltd (GRML)	United States	$2.362B
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Immunocore Holdings plc (IMCR)		$1.613B	-90.43